TrialCancer gene therapy2017

Phase I/II clinical trial to assess safety and efficacy of intratumoral and subcutaneous injection of HVJ-E in castration-resistant prostate cancer patients.

K Fujita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.